{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T13:55:59Z","timestamp":1786802159527,"version":"build-2736575974"},"reference-count":17,"publisher":"American Veterinary Medical Association (AVMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Assess efficacy of ropinirole versus apomorphine in inducing vomiting in dogs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>ANIMALS<\/jats:title>\n<jats:p>279 client-owned dogs with known or suspected ingestion of a foreign material (n = 129) or toxin (150) between August 2021 and February 2022.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>PROCEDURES<\/jats:title>\n<jats:p>In this non-randomized non-controlled clinical trial, ropinirole topical ophthalmic solution was applied to dogs\u2019 eyes, with a target dose of 3.75 mg\/m<jats:sup>2<\/jats:sup>. A second dose was administered after 15 minutes based on clinician discretion. Reversal with metoclopramide was provided based on clinician discretion. Results of ropinirole\u2019s efficacy were compared to previous literature assessing the efficacy of apomorphine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Of 279 dogs, 255 (91.4%) vomited after ropinirole administration, including 116 of the 129 dogs (89.9%) dogs that ingested foreign material and 139 of the 150 dogs (92.7%) that ingested toxins. Success of emesis did not differ between groups. With a single dose of ropinirole, 78.9% produced vomit. Fifty-nine dogs received 2 doses of ropinirole, resulting in 79.7% that produced vomit. Overall, 74.2% of the dogs vomited all the expected ingested material. Average time to emesis was 11.0 minutes with 50% of dogs vomiting within 7 to 18 minutes. Adverse effects were observed for 17.0% of dog and were self-limiting. Ropinirole was less effective than apomorphine in inducing vomiting (91.4% ropinirole, 95.6% apomorphine [<jats:italic>P<\/jats:italic> &lt; .0001]) and equally effective at evacuating all ingested material (74.2% ropinirole, 75.6% apomorphine [<jats:italic>P<\/jats:italic> = .245]).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CLINICAL RELEVANCE<\/jats:title>\n<jats:p>Ropinirole ophthalmic solution is a safe and effective emetic for use in dogs. It has a small but statistically significant decrease in efficacy compared to IV apomorphine.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/javma.23.01.0027","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T18:02:43Z","timestamp":1681840963000},"page":"1140-1146","source":"Crossref","is-referenced-by-count":8,"title":["Ropinirole has similar efficacy to apomorphine for induction of emesis and removal of foreign and toxic gastric material in dogs"],"prefix":"10.2460","volume":"261","author":[{"given":"Natalie A.","family":"Rosenstein","sequence":"first","affiliation":[{"name":"Ocean State Veterinary Specialists, East Greenwich, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Ocean State Veterinary Specialists, East Greenwich, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Kirchofer","sequence":"additional","affiliation":[{"name":"Ocean State Veterinary Specialists, East Greenwich, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Textbook of Veterinary Internal Medicine","first-page":"610","article-title":"Vomiting and regurgitation","author":"Gallagher A","year":"2016","unstructured":"Gallagher A. Vomiting and regurgitation. In: Ettinger SJ, ed. Textbook of Veterinary Internal Medicine. 8th ed. WB Saunders Co; 2016:610\u2013618."},{"issue":"4","key":"ref2","series-title":"Front Neuroendocrinol","first-page":"301","article-title":"The area postrema and vomiting","volume":"15","author":"Miller AD","year":"1994","unstructured":"Miller AD, Leslie RA. The area postrema and vomiting. Front Neuroendocrinol. 1994;15(4):301\u2013320. doi:10.1006\/frne.1994.1012"},{"issue":"2","key":"ref3","series-title":"Ann Palliat Med","first-page":"121","article-title":"Opioid-induced nausea and vomiting","volume":"1","author":"Smith HS","year":"2012","unstructured":"Smith HS, Smith JM, Seidner P. Opioid-induced nausea and vomiting. Ann Palliat Med. 2012;1(2):121\u2013129. doi:10.3978\/j.issn.2224-5820.2012.07.08"},{"issue":"5","key":"ref4","series-title":"Molecules","first-page":"5289","article-title":"The pharmacological properties and therapeutic use of apomorphine","volume":"17","author":"Ribari\u010d S","year":"2012","unstructured":"Ribari\u010d S. The pharmacological properties and therapeutic use of apomorphine. Molecules. 2012;17(5):5289\u20135309. doi:10.3390\/molecules17055289"},{"issue":"1","key":"ref5","series-title":"Eur J Pharmacol","first-page":"61","article-title":"Central mechanisms for apomorphine induced emesis in the dog","volume":"144","author":"Harding RK","year":"1987","unstructured":"Harding RK, Hugenholtz H, Kucharczyk J, Lemoine J. Central mechanisms for apomorphine induced emesis in the dog. Eur J Pharmacol. 1987;144(1):61\u201365. doi:10.1016\/0014-2999(87)90009-4"},{"key":"ref6","series-title":"Am J Vet Res","first-page":"1360","article-title":"Safety and efficacy of an ocular insert for apomorphine-induced emesis in dogs","volume":"69","author":"Cote DD","year":"2008","unstructured":"Cote DD, Collins DM, Burczynski FJ. Safety and efficacy of an ocular insert for apomorphine-induced emesis in dogs. Am J Vet Res. 2008;69:1360\u20131365."},{"key":"ref7","first-page":"67","article-title":"Plumb\u2019s Veterinary Drug Handbook","author":"Plumb DC","year":"2018","unstructured":"Plumb DC. Plumb\u2019s Veterinary Drug Handbook. 9th ed. Wiley-Blackwell; 2018:67\u201369."},{"key":"ref8","article-title":"Freedom of Information Summary","author":"Schafer JH","unstructured":"Schafer JH. Freedom of Information Summary. Original New Animal Drug Application. Clevor. Ropinirole Ophthalmic Solution. FDA. Accessed December 4, 2021. https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/9248"},{"issue":"9","key":"ref9","series-title":"J Pharm Pharmacol","first-page":"1129","article-title":"Comparative pharmacological study of ropinirole (SKF-101468) and its metabolites in rats","volume":"52","author":"Reavill C","year":"2000","unstructured":"Reavill C, Boyfield I, Coldwell M, Nelson P. Comparative pharmacological study of ropinirole (SKF-101468) and its metabolites in rats. J Pharm Pharmacol. 2000;52(9):1129\u20131135. doi:10.1211\/0022357001774895"},{"issue":"9","key":"ref10","series-title":"Vet Rec","first-page":"283","article-title":"Ropinirole eye drops induce vomiting effectively in dogs: a randomised, double-blind, placebo-controlled clinical study","volume":"186","author":"Suokko M","year":"2020","unstructured":"Suokko M, Saloranta L, Lamminen T, Laine T, Elliott J. Ropinirole eye drops induce vomiting effectively in dogs: a randomised, double-blind, placebo-controlled clinical study. Vet Rec. 2020;186(9):283\u2013283. doi:10.1136\/vr.104953"},{"key":"ref11","article-title":"Vetoquinol USA, Inc; 2020","unstructured":"CLEVOR-Ropinirole Hydrochloride Solution [US Produce Label for Dogs]. Vetoquinol USA, Inc; 2020."},{"issue":"4","key":"ref12","series-title":"J Am Vet Med Assoc","first-page":"459","article-title":"Efficacy of intravenous administration of apomorphine for removal of gastric foreign material in dogs: 495 cases (2010-2015)","volume":"255","author":"Kirchofer KS","year":"2019","unstructured":"Kirchofer KS, Block G, Johnson JA. Efficacy of intravenous administration of apomorphine for removal of gastric foreign material in dogs: 495 cases (2010-2015). J Am Vet Med Assoc. 2019;255(4):459\u2013465. doi:10.2460\/javma.255.4.459"},{"key":"ref13","series-title":"J Am Vet Med Assoc","first-page":"1179","article-title":"Effectiveness and adverse effects of the use of apomorphine and 3% hydrogen peroxide solution to induce emesis in dogs","volume":"241","author":"Khan SA","year":"2012","unstructured":"Khan SA, Mclean MK, Slater M,  Effectiveness and adverse effects of the use of apomorphine and 3% hydrogen peroxide solution to induce emesis in dogs. J Am Vet Med Assoc. 2012;241:1179\u20131184."},{"issue":"3","key":"ref14","series-title":"J Am Vet Med Assoc","first-page":"283","article-title":"Evaluation of subcutaneous versus intravenous administration of apomorphine for induction of emesis in dogs","volume":"259","author":"Fischer C","year":"2021","unstructured":"Fischer C, Drobatz KJ, Thawley VJ. Evaluation of subcutaneous versus intravenous administration of apomorphine for induction of emesis in dogs. J Am Vet Med Assoc. 2021;259(3):283\u2013287. doi:10.2460\/javma.259.3.283"},{"key":"ref15","series-title":"J Vet Pharmacol Ther","first-page":"154","article-title":"Apomorphine-induced emesis in the dog\u2014routes of administration, efficacy and synergism by naloxone","volume":"13","author":"Scherkl R","year":"1990","unstructured":"Scherkl R, Hashem A, Frey HH. Apomorphine-induced emesis in the dog\u2014routes of administration, efficacy and synergism by naloxone. J Vet Pharmacol Ther. 1990;13:154\u2013158."},{"issue":"6","key":"ref16","series-title":"Clin Auton Res","first-page":"303","article-title":"Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs","volume":"4","author":"Montastruc JL","year":"1994","unstructured":"Montastruc JL, Lapeyre-Mestre M, Llau ME, Senard JM, Rascol O, Montastruc P. Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs. Clin Auton Res. 1994;4(6):303\u2013305. doi:10.1007\/BF01821529"},{"issue":"1","key":"ref17","series-title":"Toxicol Rev","first-page":"51","article-title":"Hydrogen peroxide poisoning","volume":"23","author":"Watt BE","year":"2004","unstructured":"Watt BE, Proudfoot AT, Vale JA. Hydrogen peroxide poisoning. Toxicol Rev. 2004;23(1):51\u201357. doi:10.2165\/00139709-200423010-00006"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/8\/javma.23.01.0027.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/8\/javma.23.01.0027.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/8\/javma.23.01.0027.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:02:02Z","timestamp":1741352522000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/8\/javma.23.01.0027.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":17,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.2460\/javma.23.01.0027","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}